Menu
Patent
The patented and in-house developed treatment system Q-PRO® with IDOSE® is based on our own patents. The patent portfolio is significant, eight patent families with twelve approved patents. The basic patents relating to the function of our laser system are approved in Europe, the USA, China and Japan, among others.
Four patent families concern the protection of the technical solutions that make the system use the same optical fibers for measurement as for treatment. One patent family relates to the protection of a disposable article for sterile optical fibers. Three patent families relate to different methods for performing dose recalculation during ongoing treatment, i.e. the IDOSE® technology.
SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects.